This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Staudt, M. R. Articles by Dittmer, D. P. Search for Related Content PubMed PubMed Citation Articles by Staudt, M. R. Articles by Dittmer, D. P.

The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo

¹ Graduate Program in Microbiology and Immunology and ² Department of Microbiology and Immunology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; ³ Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts; and ⁴ Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Certain lymphomas in AIDS patients, such as primary effusion lymphoma (PEL), are closely associated with the lymphotropic herpes virus Kaposi’s sarcoma-associated herpes virus (KSHV), also called human herpesvirus 8. The virus is thought to be essential for tumorigenesis, yet systems to investigate PEL in vivo are rare. Here we describe PEL tumorigenesis in a new xenograft model. Embedded in Matrigel, PEL cells formed rapid, well-organized, and angiogenic tumors after s.c. implantation of C.B.17 SCID mice. Without Matrigel we did not observe comparable tumors, which implies that extracellular support and/or signaling aids PEL. All of the tumors maintained the KSHV genome, and the KSHV latent protein LANA/orf73 was uniformly expressed. However, the expression profile for key lytic mRNAs, as well as LANA-2/vIRF3, differed between tissue culture and sites of implantation. We did not observe a net effect of ganciclovir on PEL growth in culture or as xenograft. These findings underscore the importance of the microenvironment for PEL tumorigenesis and simplify the preclinical evaluation of potential anticancer agents.

This article has been cited by other articles:

				A. J. O'Hara, W. Vahrson, and D. P. Dittmer Gene alteration and precursor and mature microRNA transcription changes contribute to the miRNA signature of primary effusion lymphoma Blood, February 15, 2008; 111(4): 2347 - 2353. [Abstract] [Full Text] [PDF]

				D. A. Davis, K. E. Singer, I. P. Reynolds, M. Haque, and R. Yarchoan Hypoxia Enhances the Phosphorylation and Cytotoxicity of Ganciclovir and Zidovudine in Kaposi's Sarcoma-Associated Herpesvirus Infected Cells Cancer Res., July 15, 2007; 67(14): 7003 - 7010. [Abstract] [Full Text] [PDF]

				S.-H. Sin, D. Roy, L. Wang, M. R. Staudt, F. D. Fakhari, D. D. Patel, D. Henry, W. J. Harrington Jr, B. A. Damania, and D. P. Dittmer Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Blood, March 1, 2007; 109(5): 2165 - 2173. [Abstract] [Full Text] [PDF]

				C. E. Petre, S.-H. Sin, and D. P. Dittmer Functional p53 Signaling in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas: Implications for Therapy J. Virol., February 15, 2007; 81(4): 1912 - 1922. [Abstract] [Full Text] [PDF]

				F.-Q. An, H. M. Folarin, N. Compitello, J. Roth, S. L. Gerson, K. R. McCrae, F. D. Fakhari, D. P. Dittmer, and R. Renne Long-Term-Infected Telomerase-Immortalized Endothelial Cells: a Model for Kaposi's Sarcoma-Associated Herpesvirus Latency In Vitro and In Vivo. J. Virol., May 1, 2006; 80(10): 4833 - 4846. [Abstract] [Full Text] [PDF]

				L. Wang, D. P. Dittmer, C. C. Tomlinson, F. D. Fakhari, and B. Damania Immortalization of Primary Endothelial Cells by the K1 Protein of Kaposi's Sarcoma-Associated Herpesvirus. Cancer Res., April 1, 2006; 66(7): 3658 - 3666. [Abstract] [Full Text] [PDF]

				H. Chang, D. P. Dittmer, S.-Y. Chul, Y. Hong, and J. U. Jung Role of Notch Signal Transduction in Kaposi's Sarcoma-Associated Herpesvirus Gene Expression J. Virol., November 15, 2005; 79(22): 14371 - 14382. [Abstract] [Full Text] [PDF]

				A. Godfrey, J. Anderson, A. Papanastasiou, Y. Takeuchi, and C. Boshoff Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA Blood, March 15, 2005; 105(6): 2510 - 2518. [Abstract] [Full Text] [PDF]